Stamford, CT -- (SBWIRE) -- 01/02/2014 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Organovo Holdings Inc (NYSEMKT:ONVO), Immunomedics, Inc. (NASDAQ:IMMU), Gastar Exploration Inc (NYSEMKT:GST), Noah Holdings Limited (ADR) (NYSE:NOAH)
Organovo Holdings Inc (NYSEMKT:ONVO) opened the session at $10.47, trading in a range of $10..13 - $11.54,. The stock showed a positive performance of +12.84% in the last trading session from its previous close of $9.81 and closed at $11.07. The stock traded on a volume of 11.68 million shares and the average volume of the stock remained 6.46 million shares. Organovo Holdings, Inc. develops three-dimensional (3D) bioprinting technology for creating functional human tissues on demand for research and medical applications. The company?s 3D NovoGen bioprinting technology works across various tissue and cell types, and allows for the placement of cells in desired pattern.
For How Long ONVO will Fight for Profitability? Read This Trend Analysis report
Immunomedics, Inc. (NASDAQ:IMMU) traded 2.50 million shares in the last business day while the average volume of the stock remained 830,964 shares. The stock showed a positive movement of +10.31% to end at $4.60. The 52 week range of the stock remained $2.11 - $7.35. Immunomedics, Inc., a biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other serious diseases. Its products include epratuzumab, which is in two Phase III clinical trials for the treatment of lupus; Yttrium-90 labeled clivatuzumab tetraxetan, a therapeutic product candidate that completed a Phase Ib clinical trial for the treatment of pancreatic cancer; and Veltuzumab, a humanized anti-CD20 monoclonal antibody for the treatment of non-Hodgkin lymphoma (NHL).
For How Long IMMU’s Gloss will Attract Investors? Find out via this report
Gastar Exploration Inc (NYSEMKT:GST) reported 3.13 million shares were exchanged during the last trade, while the average volume is about 983,040 shares. The stock escalated +8.46% and finished the day at $6.92. The beta of the stock is recorded at 1.23. Gastar Exploration Inc., an independent energy company, explores for, develops, and produces natural gas, natural gas liquids, oil, and condensate in the United States. It is primarily involved in the identification, acquisition, and subsequent exploration and development of oil and natural gas properties focusing on unconventional reserves, such as shale resource plays.
For How Long GST’s Gloss will Attract Investors? Find out via this report
Noah Holdings Limited (ADR) (NYSE:NOAH) shares rose, +8.24 percent from its previous close of $16.63 to close at $18.00. Traded with volume of 1.24 million shares in the prior session and the average volume of the stock remained 600,644 shares. Noah Holdings Limited, through its subsidiaries, operates as a wealth management service provider with focus on distributing wealth management products in the People?s Republic of China. The company?s distributed products include fixed income products, including collateralized fixed income products sponsored by trust companies and real estate funds managed that provide investors with fixed rates of return; private equity funds products comprising investments in various private equity funds sponsored by domestic and internal fund management firms, funds of funds and real estate funds, and the underlying assets that are portfolios of equity investments in unlisted private companies; and other products.
Why Should Investors Buy NOAH After The Recent Gain? Just Go Here and Find Out
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Read full disclaimer at: http://otcstockpicks.net/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)